Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 831

1.

Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study.

Young WB, Ivan Lopez J, Rothrock JF, Orejudos A, Manack Adams A, Lipton RB, Blumenfeld AM.

J Headache Pain. 2019 Jan 22;20(1):10. doi: 10.1186/s10194-018-0952-1.

PMID:
30669961
2.

Depressive Symptoms Predict Incident Dementia in a Community Sample of Older Adults: Results From the Einstein Aging Study.

Ezzati A, Katz MJ, Derby CA, Zimmerman ME, Lipton RB.

J Geriatr Psychiatry Neurol. 2019 Jan 10:891988718824036. doi: 10.1177/0891988718824036. [Epub ahead of print]

PMID:
30630387
3.

Migraine Progression: A Systematic Review.

Buse DC, Greisman JD, Baigi K, Lipton RB.

Headache. 2018 Dec 27. doi: 10.1111/head.13459. [Epub ahead of print] Review.

PMID:
30589090
4.

The temporal relationship between pain intensity and pain interference and incident dementia.

Ezzati A, Wang C, Katz MJ, Derby CA, Zammit AR, Zimmerman ME, Pavlovic JM, Sliwinski MJ, Lipton RB.

Curr Alzheimer Res. 2018 Dec 12. doi: 10.2174/1567205016666181212162424. [Epub ahead of print]

PMID:
30543173
5.

Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.

Zammit AR, Muniz-Terrera G, Katz MJ, Hall CB, Ezzati A, Bennett DA, Lipton RB.

J Alzheimers Dis. 2019;67(1):125-135. doi: 10.3233/JAD-180737.

6.

Parkinson's disease: Evolution of the scientific literature from 1983 to 2017 by countries and journals.

Robert C, Wilson CS, Lipton RB, Arreto CD.

Parkinsonism Relat Disord. 2018 Nov 10. pii: S1353-8020(18)30495-4. doi: 10.1016/j.parkreldis.2018.11.011. [Epub ahead of print] Review.

PMID:
30455157
7.

Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.

Kuca B, Silberstein SD, Wietecha L, Berg PH, Dozier G, Lipton RB; COL MIG-301 Study Group.

Neurology. 2018 Dec 11;91(24):e2222-e2232. doi: 10.1212/WNL.0000000000006641. Epub 2018 Nov 16.

8.

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease.

Peloso GM, van der Lee SJ; International Genomics of Alzheimer's Project (IGAP), Destefano AL, Seshardi S.

Alzheimers Dement (Amst). 2018 Sep 22;10:595-598. doi: 10.1016/j.dadm.2018.08.008. eCollection 2018.

9.

Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Buse DC, Rains JC, Pavlovic JM, Fanning KM, Reed ML, Manack Adams A, Lipton RB.

Headache. 2019 Jan;59(1):32-45. doi: 10.1111/head.13435. Epub 2018 Nov 1.

PMID:
30381821
10.

Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials.

Porter JK, Di Tanna GL, Lipton RB, Sapra S, Villa G.

Pharmacoecon Open. 2018 Oct 30. doi: 10.1007/s41669-018-0105-0. [Epub ahead of print]

11.

Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.

Dodick DW, Tepper SJ, Lipton RB, Buse DC, Stewart WF, Bayliss M, Desai P, Sapra S, Anderson K, McInerney-Prichard E.

Headache. 2018 Oct;58(9):1358-1372. doi: 10.1111/head.13426.

PMID:
30362524
12.

Visual memory tests enhance the identification of amnestic MCI cases at greater risk of Alzheimer's disease.

Oltra-Cucarella J, Sánchez-SanSegundo M, Lipnicki DM, Crawford JD, Lipton RB, Katz MJ, Zammit AR, Scarmeas N, Dardiotis E, Kosmidis MH, Guaita A, Vaccaro R, Kim KW, Han JW, Kochan NA, Brodaty H, Pérez-Vicente JA, Cabello-Rodríguez L, Sachdev PS, Ferrer-Cascales R; Cohort Studies of Memory in an International Consortium (COSMIC).

Int Psychogeriatr. 2018 Oct 25:1-10. doi: 10.1017/S104161021800145X. [Epub ahead of print]

PMID:
30355384
13.

Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.

Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.

Headache. 2018 Oct;58(9):1408-1426. doi: 10.1111/head.13407. Epub 2018 Oct 20.

PMID:
30341895
14.

The Association of Changes in Pain Acceptance and Headache-Related Disability.

Lillis J, Thomas JG, Lipton RB, Rathier L, Roth J, Pavlovic J, O'Leary KC, Bond DS.

Ann Behav Med. 2018 Oct 5. doi: 10.1093/abm/kay076. [Epub ahead of print]

PMID:
30289426
15.

Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.

Zammit AR, Hall CB, Katz MJ, Muniz-Terrera G, Ezzati A, Bennett DA, Lipton RB.

J Alzheimers Dis. 2018;66(1):347-357. doi: 10.3233/JAD-180604.

16.

Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study.

Katz MJ, Wang C, Derby CA, Lipton RB, Zimmerman ME, Sliwinski MJ, Rabin LA.

J Alzheimers Dis. 2018;66(1):239-248. doi: 10.3233/JAD-180335.

PMID:
30282356
17.

Negative and positive affect as predictors of inflammation: Timing matters.

Graham-Engeland JE, Sin NL, Smyth JM, Jones DR, Knight EL, Sliwinski MJ, Almeida DM, Katz MJ, Lipton RB, Engeland CG.

Brain Behav Immun. 2018 Nov;74:222-230. doi: 10.1016/j.bbi.2018.09.011. Epub 2018 Sep 11.

PMID:
30217538
18.

American Headache Society Survey About Urgent and Emergency Management of Headache Patients.

Minen MT, Ortega E, Lipton RB, Cowan R.

Headache. 2018 Oct;58(9):1389-1396. doi: 10.1111/head.13387. Epub 2018 Sep 12.

PMID:
30207384
19.

Repeated Spiral Drawings in Essential Tremor: a Possible Limb-Based Measure of Motor Learning.

Kim CY, Luo L, Yu Q, Mirallave A, Saunders-Pullman R, Lipton RB, Louis ED, Pullman SL.

Cerebellum. 2018 Sep 11. doi: 10.1007/s12311-018-0974-x. [Epub ahead of print]

PMID:
30206795
20.

Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.

VanderPluym J, Dodick DW, Lipton RB, Ma Y, Loupe PS, Bigal ME.

Neurology. 2018 Sep 18;91(12):e1152-e1165. doi: 10.1212/01.wnl.0000544321.19316.40. Epub 2018 Aug 17.

21.

Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab.

Ayer DW, Skljarevski V, Ford JH, Nyhuis AW, Lipton RB, Aurora SK.

Headache. 2018 Sep;58(8):1225-1235. doi: 10.1111/head.13383. Epub 2018 Aug 14.

PMID:
30106172
22.

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.

Buse DC, Lipton RB, Hallström Y, Reuter U, Tepper SJ, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA.

Cephalalgia. 2018 Sep;38(10):1622-1631. doi: 10.1177/0333102418789072. Epub 2018 Aug 7.

PMID:
30086681
23.

MRI-defined White Matter Microstructural Alteration Associated with Soccer Heading Is More Extensive in Women than Men.

Rubin TG, Catenaccio E, Fleysher R, Hunter LE, Lubin N, Stewart WF, Kim M, Lipton RB, Lipton ML.

Radiology. 2018 Nov;289(2):478-486. doi: 10.1148/radiol.2018180217. Epub 2018 Jul 31.

PMID:
30063172
24.

Qualitative Change in Migraine Prevention?

Cady R, Lipton RB.

Headache. 2018 Jul;58(7):1092-1095. doi: 10.1111/head.13354. Epub 2018 Jul 23.

PMID:
30035299
25.

Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Lipton RB, Fanning KM, Buse DC, Martin VT, Reed ML, Manack Adams A, Goadsby PJ.

Headache. 2018 Jul;58(7):933-947. doi: 10.1111/head.13342. Epub 2018 Jul 19.

PMID:
30024028
26.

Heading and unintentional head impacts have opposing associations with Patient Reported Outcomes in amateur soccer players.

Hunter LE, Ifrah C, Zimmerman ME, Kim M, Lipton RB, Stewart WF, Lipton ML.

Res Sports Med. 2018 Oct-Dec;26(4):390-400. doi: 10.1080/15438627.2018.1492396. Epub 2018 Jul 13.

PMID:
30003822
27.

Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.

Scher AI, Wang SJ, Katsarava Z, Buse DC, Fanning KM, Adams AM, Lipton RB.

Cephalalgia. 2018 Jan 1:333102418786266. doi: 10.1177/0333102418786266. [Epub ahead of print]

PMID:
29996667
28.

A Gray Matter Volume Covariance Network Associated with the Motoric Cognitive Risk Syndrome: A Multi-Cohort MRI Study.

Blumen HM, Allali G, Beauchet O, Lipton RB, Verghese J.

J Gerontol A Biol Sci Med Sci. 2018 Jul 6. doi: 10.1093/gerona/gly158. [Epub ahead of print]

PMID:
29985983
29.

Personality and Risk Taking in Sports: A Focus on Unintentional and Intentional Head Impacts in Amateur Soccer Players.

Levitch CF, Ifrah C, Kim M, Stewart WF, Lipton RB, Zimmerman ME, Lipton ML.

Clin J Sport Med. 2018 Jun 21. doi: 10.1097/JSM.0000000000000627. [Epub ahead of print]

PMID:
29933278
30.

Exploring the impact of comorbid primary headaches and neck pain.

Ashina S, Lipton RB.

Scand J Pain. 2015 Jul 1;8(1):23-24. doi: 10.1016/j.sjpain.2015.03.002. No abstract available.

PMID:
29911620
31.

Comment: Noninvasive neurostimulation for migraine should be part of the general neurologist's therapeutic armamentarium.

Lipton RB, Goadsby PJ.

Neurology. 2018 Jul 24;91(4):167. doi: 10.1212/WNL.0000000000005870. Epub 2018 Jun 15. No abstract available.

PMID:
29907607
32.

DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.

Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM.

Headache. 2018 May;58(5):676-687. doi: 10.1111/head.13309.

PMID:
29878341
33.

Factors Related to Migraine Patients' Decisions to Initiate Behavioral Migraine Treatment Following a Headache Specialist's Recommendation: A Prospective Observational Study.

Minen MT, Azarchi S, Sobolev R, Shallcross A, Halpern A, Berk T, Simon NM, Powers S, Lipton RB, Seng E.

Pain Med. 2018 Nov 1;19(11):2274-2282. doi: 10.1093/pm/pny028.

PMID:
29878178
34.

User Design and Experience Preferences in a Novel Smartphone Application for Migraine Management: A Think Aloud Study of the RELAXaHEAD Application.

Minen MT, Jalloh A, Ortega E, Powers SW, Sevick MA, Lipton RB.

Pain Med. 2018 May 30. doi: 10.1093/pm/pny080. [Epub ahead of print]

PMID:
29868895
35.

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.

Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC, Dodick DW, Lipton RB.

J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-z.

36.

Heading Frequency Is More Strongly Related to Cognitive Performance Than Unintentional Head Impacts in Amateur Soccer Players.

Stewart WF, Kim N, Ifrah C, Sliwinski M, Zimmerman ME, Kim M, Lipton RB, Lipton ML.

Front Neurol. 2018 Apr 24;9:240. doi: 10.3389/fneur.2018.00240. eCollection 2018.

37.

Assessing Physician-Patient Dialogues About Chronic Migraine During Routine Office Visits.

Buse DC, Gillard P, Arctander K, Kuang AW, Lipton RB.

Headache. 2018 Jul;58(7):993-1006. doi: 10.1111/head.13314. Epub 2018 May 4.

PMID:
29727478
38.

Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: a systematic review and meta-analysis of individual participant data.

Eurelings LS, van Dalen JW, Ter Riet G, Moll van Charante EP, Richard E, van Gool WA; ICARA Study Group.

Clin Epidemiol. 2018 Apr 4;10:363-379. doi: 10.2147/CLEP.S150915. eCollection 2018. Review.

39.

Gray matter volume covariance patterns associated with gait speed in older adults: a multi-cohort MRI study.

Blumen HM, Brown LL, Habeck C, Allali G, Ayers E, Beauchet O, Callisaya M, Lipton RB, Mathuranath PS, Phan TG, Pradeep Kumar VG, Srikanth V, Verghese J.

Brain Imaging Behav. 2018 Apr 9. doi: 10.1007/s11682-018-9871-7. [Epub ahead of print]

PMID:
29629501
40.

Neuroticism, rumination, negative affect, and sleep: Examining between- and within-person associations.

Slavish DC, Sliwinski MJ, Smyth JM, Almeida DM, Lipton RB, Katz MJ, Graham-Engeland JE.

Pers Individ Dif. 2018 Mar 1;123:217-222. doi: 10.1016/j.paid.2017.11.023. Epub 2017 Nov 23. No abstract available.

PMID:
29610545
41.

Increases in Neuroticism May Be an Early Indicator of Dementia: A Coordinated Analysis.

Yoneda T, Rush J, Graham EK, Berg AI, Comijs H, Katz M, Lipton RB, Johansson B, Mroczek DK, Piccinin AM.

J Gerontol B Psychol Sci Soc Sci. 2018 Mar 28. doi: 10.1093/geronb/gby034. [Epub ahead of print]

PMID:
29608748
42.

Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective.

Lipton RB, Brennan A, Palmer S, Hatswell AJ, Porter JK, Sapra S, Villa G, Shah N, Tepper S, Dodick D.

J Med Econ. 2018 Jul;21(7):666-675. doi: 10.1080/13696998.2018.1457533. Epub 2018 Apr 3.

PMID:
29571276
43.

Temporal unfolding of declining episodic memory on the Free and Cued Selective Reminding Test in the predementia phase of Alzheimer's disease: Implications for clinical trials.

Grober E, Veroff AE, Lipton RB.

Alzheimers Dement (Amst). 2018 Jan 12;10:161-171. doi: 10.1016/j.dadm.2017.12.004. eCollection 2018.

44.

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).

Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW.

Cephalalgia. 2018 May;38(6):1038-1048. doi: 10.1177/0333102418762525. Epub 2018 Mar 4.

45.

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.

Tassorelli C, Diener HC, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ; International Headache Society Clinical Trials Standing Committee.

Cephalalgia. 2018 Apr;38(5):815-832. doi: 10.1177/0333102418758283. Epub 2018 Mar 4.

PMID:
29504482
46.

Recalled early life adversity and pain: the role of mood, sleep, optimism, and control.

Mathur A, Graham-Engeland JE, Slavish DC, Smyth JM, Lipton RB, Katz MJ, Sliwinski MJ.

J Behav Med. 2018 Aug;41(4):504-515. doi: 10.1007/s10865-018-9917-8. Epub 2018 Feb 21.

PMID:
29468533
47.

The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility.

Steiner TJ, Buse DC, Al Jumah M, Westergaard ML, Jensen RH, Reed ML, Prilipko L, Mennini FS, Láinez MJA, Ravishankar K, Sakai F, Yu SY, Fontebasso M, Al Khathami A, MacGregor EA, Antonaci F, Tassorelli C, Lipton RB; Lifting The Burden: The Global Campaign against Headache.

J Headache Pain. 2018 Feb 14;19(1):15. doi: 10.1186/s10194-018-0842-6.

48.

Behavioral interventions as a treatment for epilepsy: A multicenter randomized controlled trial.

Haut SR, Lipton RB, Cornes S, Dwivedi AK, Wasson R, Cotton S, Strawn JR, Privitera M.

Neurology. 2018 Mar 13;90(11):e963-e970. doi: 10.1212/WNL.0000000000005109. Epub 2018 Feb 14.

PMID:
29444968
49.

Memory Binding Test Predicts Incident Dementia: Results from the Einstein Aging Study.

Mowrey WB, Lipton RB, Katz MJ, Ramratan WS, Loewenstein DA, Zimmerman ME, Buschke H.

J Alzheimers Dis. 2018;62(1):293-304. doi: 10.3233/JAD-170714.

PMID:
29439336
50.

The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research.

Steiner TJ, Lipton RB; Lifting The Burden: The Global Campaign against Headache.

J Headache Pain. 2018 Feb 2;19(1):12. doi: 10.1186/s10194-018-0837-3.

Supplemental Content

Loading ...
Support Center